CTTHOTCPharmaceutical PreparationsFiscal year ends December 31
CTT PHARMACEUTICAL HOLDINGS, INC.
Financials through Q3 FY2015, quarter ended Sep 30, 2015Last filing: 10-Q on Sep 17, 2026
$0.06−0.00 (-0.17%)
Close on Oct 16, 2026
- Market cap
- $1.26M
- P/E (TTM)
- –
- Dividend yield
- –
Earnings
Quarterly results announced on Form 8-K, Item 2.02
No earnings releases found
Ctt Pharmaceutical has not filed an earnings release (Form 8-K, Item 2.02) that we could match to a fiscal quarter.
Press releases
Announcements Ctt Pharmaceutical filed with the SEC
CTT Pharma Receives U.S. Patent Approval
Other events · EX-99.1 to Form 8-K